子宫内膜癌中的种族差异:26年后我们身处何地?
本文对1997至2023年有关非裔美国女性(AAW)与白人美国女性(WAW)子宫内膜癌种族差异的英文文献进行快速系统综述。综述期间AAW的发病率上升39%、死亡率上升26%,而WAW发病率上升2%、死亡率升幅比AAW低9%;AAW不良预后因素更多、合并症更多、收入与保险覆盖更低、接受手术化疗放疗更少。作者结论为26年大量研究后差异反而扩大,仅靠现有研究不足以消除差异。
要点
- 1997至2023年AAW子宫内膜癌发病率上升39%、死亡率上升26%。
- 同期WAW发病率上升2%,死亡率升幅比AAW低9%。
- AAW不良预后因素、合并症更多,收入与保险覆盖更低,接受手术化疗放疗更少。
核心结论
- 在26年大量研究期间,WAW与AAW之间子宫内膜癌发病率与死亡率的种族差异扩大,提示仅靠现有研究不足以消除该差异。
- 基于本快速系统综述,作者识别并分析了因果变量对该差异的影响,并提出了强烈且相关的建议以缓解这一不断扩大的种族差异。
研究设计与样本
- 快速系统综述,检索1997至2023年发表的关于AAW与WAW子宫内膜癌种族差异的英文文献。
- 综述内容涵盖发病率与生存趋势、已知不良预后因素(诊断分期、组织学亚型、分级)、合并症、治疗差异(手术、放疗、化疗)、社会经济因素、生物学与遗传标志物差异以及政策/宣言。
主要发现
- 1997至2023年期间,AAW的疾病发病率上升39%、死亡率上升26%。
- 同期WAW的发病率上升2%,死亡率上升但升幅比AAW低9%。
- AAW当前29.4%的发病率与26年前的17.8%相比出现逆转。
- 与WAW相比,AAW不良预后变量患病率更高、合并症更多、收入水平更低、保险覆盖更少,且接受手术、化疗和放疗更不充分。
- 迄今尚未识别出可操作的分子/遗传标志物。
关键数值与推荐
- AAW发病率上升39%,WAW发病率上升2%。
- AAW死亡率上升26%,WAW死亡率升幅比AAW低9%。
- AAW当前发病率为29.4%,26年前为17.8%。
临床怎么用
- 作者基于本快速系统综述提出了强烈且相关的建议,以缓解不断扩大的种族差异。
- 原文未据此给出具体临床推荐。
局限性
- 未能找到任何已发表的、旨在有效缓解所记录的种族差异的建议或实施策略/政策的活跃项目。
- 迄今尚未识别出可操作的分子/遗传标志物。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Endometrial cancer is the most commonly diagnosed female genital tract malignancy in the United States of America. Racial disparities surrounding this particular disease have been extensively investigated for over 26-years. We sought to determine if research in this area has led to any significant improvements in this disparity. METHODS: We performed a rapid systematic review of English language publications on racial disparities in endometrial cancer among African American (AAW) and white American women (WAW), from 1997 to 2023. We looked at trends in incidence and survival; impact of known poor prognostic factors (stage at diagnosis, histological subtypes, grade); co-morbidities; differences in treatment (surgery, radiation and chemotherapy); socioeconomic factors; differences in biological and genetic markers; and policies/declarations. RESULTS: During the period under review (1997-2023), there was a notable increase in both disease incidence (39%) and mortality (26%) rates for AAW, in comparison to WAW among whom the incidence rates increased by 2% and mortality rates rose, but 9% less than for AAW. It should be noted that the current incidence rate of 29.4% in AAW represent a reversal of what is was 26-years ago, when the incidence rate was 17.8%. In comparison to WAW, AAW had a higher prevalence of poor prognostic variables, more co-morbidities, lower income levels, less insurance coverage, and were more frequently under treated with surgery, chemotherapy and radiation. To date no actionable molecular/genetic markers have been identified. We were unable to locate any published recommendations or active programs of implementation strategies/policies designed to effectively mitigate the documented racial disparity. CONCLUSION: Racial disparities in disease incidence and mortality in endometrial cancer rates between WAW and AAW have widened during a 26-year period of robust research, suggesting that current research alone is not enough to eliminate this disparity. Based on this rapid systematic review we have identified and analyzed the impact of causation variables on this disparity. Additionally, we have made strong and pertinent recommendations for the benefit of mitigating this escalating racial disparity.
引用
- Hicks ML, Hicks MM, Mathews RP, et al. Racial disparities in endometrial cancer: Where are we after 26 years? Gynecol Oncol. 2024. PMID: 38382150. doi:10.1016/j.ygyno.2024.01.054
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。